Human Genome Epidemiology Literature Finder
|
Records 1 - 4 (of 4 Records) |
| Query Trace: Carcinoma and FLT1[original query] |
|---|
| VEGF pathway genetic variants as biomarkers of treatment outcome with bevacizumab: an analysis of data from the AViTA and AVOREN randomised trials. The Lancet. Oncology 2012 Jul 13 (7): 724-33. Lambrechts Diether, Claes Bart, Delmar Paul, Reumers Joke, Mazzone Massimiliano, Yesilyurt Betül T, Devlieger Roland, Verslype Chris, Tejpar Sabine, Wildiers Hans, de Haas Sanne, Carmeliet Peter, Scherer Stefan J, Van Cutsem Er |
| Prognostic markers and response to vandetanib therapy in sporadic medullary thyroid cancer patients. European journal of endocrinology 2016 09 175 (3): 173-80. Tiedje Vera, Ting Saskia, Walter Robert Fred, Herold Thomas, Worm Karl, Badziong Julia, Zwanziger Denise, Schmid Kurt Werner, Führer Dagm |
| Comprehensive Analysis of Driver Genes in Personal Genomes of Clear Cell Renal Cell Carcinoma. Technology in cancer research & treatment 2019 Jan 18 1533033819830966. Li Jin, Guo Liping, Chai Li, Ai Zishe |
| Hypoxia-Inducible Factor-2-Altered Urothelial Carcinoma: Clinical and Genomic Features. Current oncology (Toronto, Ont.) 2022 11 29 (11): 8638-8649. Vlachostergios Panagiotis J, Tamposis Ioannis A, Anagnostou Maria, Papathanassiou Maria, Mitrakas Lampros, Zachos Ioannis, Thodou Eleni, Samara Maria, Tzortzis Vassili |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 25, 2023
- Content source: